Infected Blood Compensation Scheme Debate

Full Debate: Read Full Debate
Department: Cabinet Office

Infected Blood Compensation Scheme

John Glen Excerpts
Wednesday 23rd October 2024

(4 weeks, 1 day ago)

Commons Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
John Glen Portrait John Glen (Salisbury) (Con)
- View Speech - Hansard - -

I thank the Paymaster General for advance notice of the statutory instrument being laid, as he has always given. He rightly reminded the House of the injustice that victims of the infected blood scandal have been subject to—one that has spanned several decades. I hope that we are now in rapid delivery mode. My role is to ensure that the Government are doing all they can to deliver compensation as swiftly and effectively as possible for the infected and affected, following the passage of the Bill under the previous Government.

As the right hon. Gentleman knows, it is also my duty to work collaboratively with the Government on this matter, supporting them and scrutinising them where appropriate. To that end, I wish to set out some issues raised with me by representatives of the infected and affected communities. First, I draw the right hon. Gentleman’s attention to the Secondary Legislation Scrutiny Committee’s second report of the Session, which found the explanatory memorandum to be

“overly complex and technical, while lacking basic information about the policy”.

To some extent, I very much sympathise. This is a very complicated matter. I suspect that the right hon. Gentleman will agree that this critical information should be easily accessible to all. Can he assure the House that he will do everything he can to ensure that the explanatory memorandum to the second set of regulations will be much clearer in language and in outlining how the policy will work practically? He rightly referred to the detailed policy paper that he published in August, with the case studies and the reference to advice and support, but the implication of what has been said is that an improvement can be made.

On the Infected Blood Compensation Authority, I echo my previous comments in welcoming the Government’s pledge to deliver the first payments by the end of the year. I know that the Paymaster General and I align in recognising the paramount importance of delivering this compensation as quickly as possible. However, currently, there is no defined timetable for when applications can be made and when payments will be processed.

Furthermore, I know the Paymaster General will find it as troubling as I do that groups of victims have previously described meeting the end-of-year deadline as “nigh on impossible”. We need to solve these trust issues. Can he outline the steps the Government and the IBCA are taking to ensure that payments will be made by the end of the year—just 10 weeks away? Can he confirm what proportion of the eligible infected community will receive their payments by the end of the year?

There is a suspicion, of which I am sure the Paymaster General is aware, that achieving payouts for the previously mentioned user group of 20 individuals by the end of the year will be used to technically satisfy the obligation he undertook to get money out of the door by the end of the year. The infected community as a whole will want to know that all of them—beyond the 20—will receive their payments in their bank accounts, and what will be the interval between the end of the year and that happening. Please could the Paymaster General explain how the user group of 20 people have found the new scheme, and how quickly their lessons can be applied to the rest of the infected community? I understand that the IBCA recently confirmed its intention to invite increasingly larger groups of people to test the service before it opens to those who are eligible. Can the Paymaster General confirm when the scheme will open to larger groups? How many will be involved? Will they include all victims, including those affected from the infected estates?

The right hon. Gentleman mentioned issues around the burden of proof. I seek clarification on the proof that victims need to provide. It appears that the burden of proof once again falls to victims, which risks going against the letter and spirit of both Sir Brian Langstaff and Sir Robert Francis’s recommendations. I recognise and am sympathetic to the challenges, given Cabinet Office officials’ advice to me when I was in his position. Locating medical records could be an issue, given that the latest case date specified in the regulations is more than 30 years ago. Can the Paymaster General outline the decision-making process of the IBCA in circumstances where medical records are apparently unavailable? What steps is he taking to ensure that rightful compensation is received when proof of infected conditions is not readily available?

I would like to move on to affected persons. In his report in May, Sir Brian Langstaff made it abundantly clear that both infected and affected persons were to be given interim payments as quickly as possible. I am therefore concerned that part 3 of this instrument defines eligible infected persons but not the affected persons. Can the Minister offer some reassurance to the affected community and confirm that he has not ignored Sir Brian Langstaff’s recommendation for the affected community? The affected community are concerned that the Government’s delays in laying the second set of regulations for them means that many elderly parents of infected victims or bereaved partners will not live to see their rightful payouts as affected individuals.

I acknowledge the drafting and timetable challenges, but it will be 10 months from the final report this May to the end of next March without any defined regulations or timetable for making a claim as an affected person. That will distress many in the affected community. I am absolutely sure that the Paymaster General does not think it is fair for those affected people to feel like second-class citizens, but will he explain what processes will be under way between now and the end of March, and will he look to publish, even in broad outline, a timetable for affected communities’ applications and the interval before payments will be received?

I am also concerned that no impact assessment has been published for this statutory instrument. Parliamentary scrutiny from all sides needs to be balanced, and fairer legislation will ensue if we can have maximum information on impact in advance, so that the evaluation process can be better informed. I know the Paymaster General has previously said that the costs of the infected blood scheme will be recognised in next week’s Budget. Can he confirm whether the Government have calculated the impact and cost of the regulations?

I shall conclude by thanking the Paymaster General for his work in this area and his transparency with me. This legislation is very technically challenging and difficult to get right. I have enormous sympathy and respect for him. However, I urge him to ensure that critical information is as readily accessible as possible to all victims, infected and affected alike, bringing as much specificity as possible to the timelines for those different communities to this House as quickly as possible, and outlining the cost of the scheme.

For many of these victims, time is of the essence, which is why we must do all we can to deliver justice as quickly and effectively as possible. I remain committed to supporting the Government where I possible can and asking questions that are as reasonable as possible where answers still need to be provided.

--- Later in debate ---
Nick Thomas-Symonds Portrait Nick Thomas-Symonds
- Hansard - - - Excerpts

I hope to be able to make an announcement about it shortly. I have told the House previously how important I think the memorialisation proposals are, and they will certainly form part of the update that I will give the House before the end of the year.

I join the Liberal Democrat spokesperson, the hon. Member for Richmond Park (Sarah Olney), in congratulating the students whom she has had with her and on the work that they did in researching this subject for her speech. What she said about a culture of cover-up was important. What Sir Brian Langstaff said was not that there was some specific conspiracy between individuals, but that there was something far more pervasive, which he described as a culture of “institutional defensiveness”. People and institutions put their own reputations above the public interest, and to tackle that the Government will be pushing forward with a duty of candour. That, in my view, will be a powerful lever that the House can pull for change, but it is not just about a change in the law. It is about leadership as well, and it is about culture and changing the culture, in order to bring about a system in which the public interest is put first and we collectively do all that we can to minimise the chances of a repetition of what has happened in relation to not just this scandal but others, such as Horizon and Hillsborough.

The hon. Lady and a number of other Members asked about the severity bands. The scheme is tariff-based, and the tariffs were developed through the work of the infected blood inquiry response expert group, whose members were appointed by the right hon. Member for Salisbury when he was Paymaster General. They were clinical and legal advisers, assisted by social care specialists. The Government then chose to improve the scheme after the engagement exercise that Sir Robert Francis carried out, as I mentioned to the right hon. Gentleman during the general election campaign.

The comparison between HIV and hepatitis C has been raised. For people infected with hepatitis C there are four severity bands, and they are designed in line with clinical diagnostic markers. Recognised health conditions, for example liver damage, have, therefore, been informed by the work of the expert group. It is correct that in comparison there is a single severity band for people infected with HIV. That is because HIV is a lifelong infection. The vast majority of people infected with HIV through blood products have experienced progression to advanced symptomatic HIV disease, including AIDS conditions, and have died as a consequence of the infection. Those who survived continue to be severely impacted by the infection, and the view of the expert group was that it was disproportionately complex and onerous to disaggregate that category into different experiences, and that contrasted with hepatitis, where there is a wide range of experiences, including both acute infections with long-term limited impacts and very serious and ultimately fatal infections. That is the approach, based on the expert group, that the Government have adopted.

Similarly, on siblings, which several Members have raised, the scheme is based on recommendations from Sir Robert Francis’s framework compensation study. It does not exclude siblings over 18 who may have been carers and provided care.

John Glen Portrait John Glen
- Hansard - -

Will the right hon. Gentleman confirm that when he assessed the June engagement exercise that Sir Robert Francis supervised, he did not resist any of the recommendations from the expert group that interrogated the scheme—apart from four or five where he thought the Government could do better—and there was no attempt either by the previous Government or his to resist the advice of the expert group who are engaged with the communities?

Nick Thomas-Symonds Portrait Nick Thomas-Symonds
- Hansard - - - Excerpts

The right hon. Gentleman is absolutely right. He took exactly the same approach that I did to the expert group. I accepted, as I told the House, 69 of the 74 recommendations, including, crucially, the continuation of the support schemes. On the other five, there were reasons of simplicity or speed—of getting compensation to people more quickly. I hope the House will take the assurance that there is that imperative to act as quickly as possible.